INTRODUCTION
============

*P. aeruginosa* is a ubiquitous environmental bacterium that causes numerous opportunistic human infections, which are clinically and epidemiologically relevant due to the difficulty associated with the treatment of these infections and the transmission of resistance mechanisms. They can remain in the environment, producing repeated relapses in inpatients, increasing their morbidity and mortality, as well as health care costs[@B1].

The pathogenicity of *Pseudomonas* is associated with numerous virulence factors, such as the presence of lipopolysaccharides, pili and flagella, which are all part of the cell structure, as well as other factors synthesized by the cell and excreted into the surrounding tissue, where the infection develops, such as toxins, proteolytic enzymes, DNases and pigments[@B2]. Biofilm formation is another virulence factor due to the biofilm\'s inherent resistance to antimicrobial agents and the selection of phenotypic variants. *P. aeruginosa* biofilm presents different resistance mechanisms that make it clinically responsible for many chronic infections, controlled by quorum sensor systems that regulate the transformation from planktonic cells into sessile ones[@B3].

It has also been shown that, depending on the type of infection, *P. aeruginosa* can adapt by changing its iron uptake system using pyoverdine or pyochelin, characterized by their high and low affinity for iron, respectively, which in turn activate the production of acute virulence factors. The success of *P. aeruginosa* in causing infections is determined by a complex interaction between pathogenicity, antimicrobial resistance and regulation networks interconnecting resistance and virulence[@B4] and these interactions are currently the subject of numerous studies.

Multidrug resistant (MDR) *P. aeruginosa* strains are capable of colonizing environments and multiplying in conditions in which the rest of bacterial species are unable, granting them an evolutionary advantage and a better ability to cause epidemic outbreaks. In a hospital setting, a pathogen must be virulent and resistant to antimicrobials for an infection to persist, leading to increased patient morbidity[@B5]. In this sense, integrons, which are mobile genetic elements that can carry bacterial genes, have also been considered responsible for the spread of resistance to many antimicrobial agents; they are not essential to bacteria, but can provide additional genes that allow them to better adapt to their environment[@B6].

In Venezuela, antimicrobial agents are frequently prescribed to the population, and currently, hospitals have a limited supply of drugs for their patients' therapies, resulting in an increasing frequency of MDR *P. aeruginosa* due to the lack of timely and adequate treatments[@B7]. Since 1989, the presence of *P. aeruginosa* has been reported in intrahospital infections in Venezuela, with different resistances to beta-lactam antibiotics, aminoglycosides and quinolones[@B8]^--^[@B10]. Reports of MDR *P. aeruginosa* strains began with metallo-beta-lactamase positive strains reported in 2004[@B11] up to MDR strains found in several hospitals[@B12]. However, there are no studies evaluating the simultaneous presence of virulence factors, resistance genes and mobile genetic elements in this species, even though they are essential to understand the pathogen\'s behavior and to design adequate therapeutic and control strategies to fight these organisms. Therefore, the objective of the present study was to evaluate how the virulence factors, resistance genes and integrons are affecting the epidemiological outcome of *P. aeruginosa strains* isolated from patients in the general hospital of Cumana, Venezuela.

MATERIALS AND METHODS
=====================

Study population and bioethical standards
-----------------------------------------

We evaluated 176 *P. aeruginosa* strains isolated from patients diagnosed with clinical infections and indications of culture and antibiogram performed in the Antonio Patricio de Alcala University Hospital (HUAPA) in Cumana, collected from June to December 2009 (62 strains), January to December 2010 (42 strains), February to December 2012 (40 strains), and January to June 2016 (32 strains). Clinical and epidemiological relevant data were collected from patients, after the signature of an informed consent form. Each strain was isolated from a different individual, and they were independent of any epidemic outbreak. Biological samples and data collection were carried out following the guidelines established by the IIBCA-UDO biosecurity and bioethics committee (CoBioBios). The presence of infection was defined using criteria established by the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC)[@B13], which classifies an infection as a healthcare-associated infection (HAI) if the date on which the specific site of the infection is detected takes place at least 48 h after the patient\'s admission[@B14].

Toxin production
----------------

Hemolysins were produced in blood agar (8.0%) cultures. A transparent halo around the colonies indicated the presence of *P. aeruginosa*\'s beta-hemolysin and the absence of a hemolysis halo was interpreted as a negative result[@B15]. Pigment production was evaluated in cetrimide agar cultures; targeted pigments were pyocyanin (blue-green), fluorescein (yellow), pyoverdine (green), pyorubin (red) and pyomelanin (brown)[@B16].

Biofilm production
------------------

Bacteria were cultured in LB media in 96-well plates to quantify the production of biofilm, using *P. aeruginosa* PA01 strain as a positive control[@B17]. A sterile broth was used as the negative control to ensure sterility and the absence of non- media-specific components. Strains were considered as non-biofilm producers when their optical densities were ≤ 0.108 (≤ Average of Negative Control + 2σ) and biofilm producers when densities were \> 0.108 (\> ANC + 2σ).

Motility tests
--------------

Motility tests were carried out in sterile Petri dishes with Luria-Bertani agar (LB) using different concentrations of agar to evaluate swarming (0.5%), swimming (0.3%) and twitching (1.2%) as the different types of motility found in *P. aeruginosa*[@B18] strains. Ten microliters of the media containing overnight cultured strains were inoculated on the agar surface for the swarming testing; while for swimming, 10 μL of the strains were inoculated into a thick agar by puncture; and for twitching, 10 μL of cultures were inoculated at the bottom of the agar. A well characterized *Proteus mirabilis* (LGM7881), swarming producer strain, and another well characterized immobile *Klebsiella pneumoniae* LGM1589 strain were used as positive and negative controls. All plates were incubated at 37 °C for 24 h. To assess the twitching motility, the agar was removed from the plate and 25 mL of 1% crystal violet dye were added, incubated for 30 min, then the stain was poured off the plate and air dried. Finally, the average diameters of the growing areas of the different types of motility were measured with a graduated ruler and expressed in millimeters (mm).

Enzymes production
------------------

DNAse activity was studied using the DNAse test to rule out the presence of deoxyribonuclease[@B19]. A transparent halo around the colonies indicated nuclease activity, whereas the lack of a halo indicated a negative result. A *Serratia marcescens* strain (ATCC 1388) was used as the control. *Pseudomonas*\'s capacity to produce proteolytic enzymes (gelatinases) was determined by using the puncture method in tubes containing 4% gelatin-agar. Total or partial medium hydrolysis attested the production of the enzyme (positive result), whereas a lack of hydrolysis was interpreted as a negative result[@B20].

Resistance phenotypes
---------------------

The agar diffusion method was used to evaluate resistance to the following antimicrobials: piperacillin/tazobactam (100/10 µg), aztreonam (30 µg), ceftazidime (30 µg), cefepime (30 µg), meropenem (10 µg), imipenem (10 µg), colistin (10 µg), polymyxin B (300 U), amikacin (30 µg), gentamicin (10 µg), tobramycin (10 µg), netilmicin (10 µg), levofloxacin (5 µg), norfloxacin (5 µg) and ciprofloxacin (5 µg). All essays were conducted using the criteria established by Clinical and Laboratory Standards Institute. Resistance phenotypes were defined using the guidelines established for *P. aeruginosa*[@B21], and strains were characterized as low-level resistant (LDR, \<3 antimicrobial categories), multidrug resistant (MDR, non-susceptible to ≥3 categories), extensively drug-resistant (XDR, non-susceptible to all but ≤2 categories), and pandrug-resistant (PDR, non-susceptible to all antimicrobial categories) after testing all categories of microbial agents used in Venezuela, except for those for which this bacterium is intrinsically resistant. The quality of antimicrobial discs and biochemical tests was verified using *Escherichia coli* (ATTC 25922) and *P. aeruginosa* (ATTC 27853) as control strains.

Detection of genes
------------------

DNA extraction was carried out using pure *P. aeruginosa* cultures. A Wizard Genomic DNA purification kit (Promega, Wisconsin, USA) was used for extraction according to the manufacturer\'s specifications. The presence of the type 3 secretion systems (SST3) *exo*S and *exo*U genes were detected by PCR using oligonucleotides ExoS-F/R (1587 pb) and ExoU-F/R (761 pb) according to Ajayi *et al*.[@B22]. Strains PA01 and PA103 were assayed as positive controls for *exo*S and *exo*U, respectively. The detection of integrases *int*1-F/R (1202 pb), *int*2-F/R (973 pb) and *int*3-F/R (239 pb) genes was conducted based on the protocol described by Fonseca *et al*.[@B23] Amplified products were run in 2% agarose gels and stained with GelRed Nucleic Acid (Biotium, California, USA) using TBE 1X buffer for 30 min at 100 V cm. The size of the fragments was estimated using a molecular marker (100 pb from Promega, and Gene Ruler 1Kb plus from Thermo Fisher Scientific, Massachussets, USA). The resulting bands were visualized by transillumination with ultraviolet light, and all gels were photographically documented.

Analysis of data
----------------

Results were presented in tables and figures. The relationships between MDR and the presence of virulence factors, clinical and epidemiological factors as well as integrons were evaluated by a binary logistic regression test, with a 95% confidence interval, using the SPSS statistical software, version 18. (IBM, New York, USA).

RESULTS
=======

Identification of resistant phenotypes
--------------------------------------

The present study demonstrated an increase in the frequency of resistant strains to beta-lactam antibiotics from 2009 to 2016, especially to carbapenems ([Figure 1](#f1){ref-type="fig"}). Strains resistant to aminoglycosides have also increased, and even though the resistance to all fluoroquinolones remained ≥ 52.0% throughout the evaluated years and it has slightly decreased in the strains isolated in 2012 and 2016. All strains were susceptible to polymyxin B and colistin. The frequency of *Pseudomonas aeruginosa* MDR and XDR phenotypes strains from HUAPA ([Figure 2](#f2){ref-type="fig"}) increased from 2009 to 2016, at the expense of the decrease of the LDR phenotype, showing a clear trend of resistance gain to more antibiotic categories.

![Frequency of *P. aeruginosa* strains resistant to betalactamics (top) as well as aminoglycosides and quinolones (bottom). TZP: piperacillin/tazobactam, CAZ: ceftazidime, FEP: cefepime, ATM: aztreonam, IPM: imipenem, MEM: meropenem, GM: gentamicin, NN: tobramycin, NET: netilmicin, AK: amikacin, CIP: ciprofloxacin, LVX: levofloxacin; NOR: norfloxacin.](1678-9946-rimtsp-61-S1678-9946201961020-gf01){#f1}

![Distribution of *P. aeruginosa* strains resistant phenotypes throughout the years. Low-level resistant (LDR, \<3 antimicrobial categories), Multidrug resistant (MDR, non-susceptible to ≥3), extensively drug-resistant strains (XDR, non-susceptible to all but ≤2 antimicrobial categories).](1678-9946-rimtsp-61-S1678-9946201961020-gf02){#f2}

Virulence factors
-----------------

Pigment was the most common virulence factor produced by Pseudomonas aeruginosa strains ([Figure 3A](#f3){ref-type="fig"}), followed by gelatinases, hemolysins and DNases ([Figures 3B](#f3){ref-type="fig"}, [3C](#f3){ref-type="fig"} and [3D](#f3){ref-type="fig"}). About 40% of the strains showed biofilm and the different types of movement. The detection of *exo*S and *exo*U genes showed the latter to be more frequent ([Figures 3A](#f3){ref-type="fig"}, [3E](#f3){ref-type="fig"} and [3F](#f3){ref-type="fig"}) and the simultaneous presence of *exo*S+*exo*U genes was found in only 1.7% of the strains.

![A) Frequency of the different virulence factors detected; example of the tests for the production of DNases (B), gelatinases (C), hemolysins (D), PCR amplification for *P. aeruginosa exo*S (E) and *exo*U (F) genes. bp: base pairs, M: molecular weight markers 100 bp ladder, C+: positive Control, C-: negative Control.](1678-9946-rimtsp-61-S1678-9946201961020-gf03){#f3}

The production of pyoverdine alone was the most frequently found bacterial phenotype ([Figure 4A](#f4){ref-type="fig"} and [4B1](#f4){ref-type="fig"}), followed by pyoverdine+fluorescein ([Figure 4B6](#f4){ref-type="fig"}), no pigment ([Figue 4B8](#f4){ref-type="fig"}) and pyoverdine+pyomelanin ([Figure 4B7](#f4){ref-type="fig"}). Simultaneous pigment production was more evident when strains were subjected to antimicrobial susceptibility tests, which showed a halo of one of the pigments around the antimicrobial disc ([Figure 4B1-7](#f4){ref-type="fig"}) and the other pigment spread across the plate. Additionally, the metallic sheen characteristic of *P. aeruginosa* ([Figure 4B5](#f4){ref-type="fig"}) has also been observed in other three strains.

![Relative frequency of types of pigments produced by *P. aeruginosa* strains: A) Examples of different pigments and pigment combinations produced in Mueller-Hinton agar with antibiotics; B) 1: pyoverdine, 2: fluorescein, 3: fluorescein + pyocyanin, 4: pyomelanin, 5: pyoverdine + pyocyanin, 6: pyoverdine + fluorescein, 7: pyoverdine + pyomelanin, and 8: no pigment.](1678-9946-rimtsp-61-S1678-9946201961020-gf04){#f4}

Association of factors
----------------------

Production of DNases, gelatinase, biofilm and pigment was not statistically associated with the level of resistance shown by the strains ([Table 1](#t1){ref-type="table"}, [Figure 5](#f5){ref-type="fig"}), whereas hemolysins production was directly related to resistance. In addition, the presence of the *exo*S gene was not statistically related to resistance, while *exo*U gene was significantly more frequent in MDR and XDR strains, compared to LDR and susceptible strains.

![Frequency of *P. aeruginosa* strains that produce virulence factors according to the resistance phenotype described in [Figure 2](#f2){ref-type="fig"}. Factors associated to MDR/XDR are highlighted with three asterisks.](1678-9946-rimtsp-61-S1678-9946201961020-gf05){#f5}

###### Statistical correlation of different virulence factors with *P. aeruginosa* strains MDR/XDR phenotypes.

  Virulence Factor   MDR/XDR   Total   P     OR(95% CI)             
  ------------------ --------- ------- ----- ------------ --------- --------------
  DNAase             **--**    24      25    49           0.343     
  **+**              70        57      127                          
  Gelatinase         **--**    10      16    26           0.106     
  **+**              84        66      150                          
  Hemolysin          **--**    22      13    35           0.044     2.3(1.0-5.3)
  **+**              72        69      141                          
  Pyoverdine         **--**    11      3     14           0.062     
  **+**              83        79      162                          
  Fluorescein        **--**    69      64    133          0.479     
  **+**              25        18      43                           
  Pyomelanin         **--**    89      77    166          0.725     
  **+**              5         5       10                           
  Swarming           **--**    50      44    94           0.996     
  **+**              41        33      74                           
  Twitching          **--**    43      54    97           0.005     0.4(0.2-0.8)
  **+**              48        23      71                           
  Swimming           **--**    51      51    102          0.271     
  **+**              40        26      66                           
  Movement           **--**    17      31    48           0.004     0.4(0.2-0.7)
  **+**              77        51      128                          
  Biofilm            **--**    56      45    101          0.776     
  **+**              38        37      75                           
  *exoS*             **--**    87      76    163          0.974     
  **+**              7         6       13                           
  *exoU*             **--**    71      38    109          \<0.001   3.6(1.9-6.8)
  **+**              23        44      67                           
  Integrase I        **--**    70      43    113          0.003     2.7(1.4-5.0)
  **+**              24        39      63                           

P: probability, OR: Odds Ratio, CI: confidence interval.

When analyzing the types of movement shown by the strains, swarming but not swimming was directly correlated, while twitching was inversely correlated to the level of resistance ([Table 1](#t1){ref-type="table"}, [Figure 5](#f5){ref-type="fig"}). When comparing the presence of any type of movement versus non-motile strains, we have also found an inverse correlation with the level of resistance.

An increase in the frequency of class I integrons has been observed for the years 2012 and 2016, compared to previous years ([Figure 6](#f6){ref-type="fig"}). Additionally, a higher frequency of these sequences was found in XDR and MDR strains when compared to LDR ones, although sensitive strains have shown the same frequency as MDRs.

![Frequency of *P. aeruginosa* strains containing class I integrons according to the resistance phenotype shown (top) and throughout the years (bottom). Resistant phenotypes as described in [Figure 2](#f2){ref-type="fig"}.](1678-9946-rimtsp-61-S1678-9946201961020-gf06){#f6}

The analysis of virulence factors as risk factors for MDR/XDR resistance has shown that the presence of hemolysin, *exo*U gene and class I integrons has increased the risk of strains to present an MDR/XDR level of resistance 2.3, 3.6 and 2.7 times higher, respectively ([Table 1](#t1){ref-type="table"}), while the presence of twitching reduced the risk of MDR/XDR resistance by 2.6 times.

Epidemiological clinical factors
--------------------------------

When MDR was analyzed with respect to the presence of epidemiological clinical factors such as age, sex, hospital unit, type of sample, length of hospital stay and previous antimicrobial treatment, a statistically significant association (P \<0.05) was found for some of these factors ([Table 2](#t2){ref-type="table"}). In this sense, patients treated at the Intensive Care Unit were 3.4 times more likely to become infected by an MDR/XDR *P. aeruginosa* strain than a LDR or a susceptible strain. In addition, patients with blood stream infection (septicemia), bronchial infection or diabetic foot ulcers were 7.9, 6.7 and 9.9 times more likely to be infected by an MDR/XDR *P. aeruginosa* strain, while patients with other types of infection (urine, sputum, ear swabs, eye and vagina) were 5 times less likely to be infected by an MDR/XDR strain.

###### Statistical correlations of different patients' clinical and epidemiological factors, (from whom *P. aeruginosa* was isolated), with MDR/XDR phenotypes.

  Factor                                                      MDR/XDR   P    OR(95% CI)                   
  --------------------------------------- ------------------- --------- ---- ------------ --------------- ---------------
  Units                                   Medical             38        27   65           0.871           
  ICU                                     10                  26        36   0.030        3.4(1.2-10.2)   
  Surgery                                 18                  9         27   0.462                        
  Outpatient                              13                  10        23   0.748                        
  Pediatric/Neonatal                      15                  10        25   0.807                        
  Sample                                  Blood               7         12   19           0.003           7.9(2.1-30.2)
  Bronchial secretion                     11                  16        27   0.003        6.7(2.0-23.0)   
  Diabetic foot ulcer                     13                  28        41   \<0.001      9.9(3.1-31.9)   
  Skin secretion                          40                  21        61   0.117                        
  Other [a](#TFN3){ref-type="table-fn"}   23                  5         28   0.002        0.2(0.1-0.6)    
  Stay                                    Short (\<10 days)   70        43   113          0.019           2.3(1.1-4.)
  Long (≥10 days)                         21                  29        50                                
  Sex                                     Male                53        55   108          0.355           
  Female                                  35                  27        62                                
  Age                                     \<10 years          13        11   24           0.964           
  10-60 years                             52                  41        93   0.721                        
  \>60 years                              16                  18        34   0.573                        
  Previous antimicrobial treatment        No                  78        44   122          \<0.001         4.2(2.1-8.4)
  Yes                                     16                  38        54                                

P: probability, OR: Odds Ratio, CI: confidence interval.

Other types of samples: urine, sputum, ear swabs, eye and vagina.

Furthermore, patients with longer hospital stay had a 2.3 times higher risk to be infected by an MDR/XDR strain, while those with a previous antimicrobial treatment showed a 4.2 times higher risk of being infected by these strains.

DISCUSSION
==========

The presence of MDR/XDR *P. aeruginosa* strains in the HUAPA hospital has increased over the past years. Teixeira *et al*.[@B24] evaluated strains between 2010 and 2011 and reported resistance to one or more antimicrobial agents in 65% of the analyzed strains. Data reported here on MDR and XDR strains have shown the severity of this medical issue for the patients attending this hospital due to the higher risk of morbidity and mortality and also the risk of spreading of resistant strains to the population living in this region. The increase of resistant strains of this species has a greater impact because of the natural resistance mechanisms that this bacterial species has.

Although most beta-lactam antibiotics are faced with lower resistance than carbapenems, this high resistance to carbapenems should be highlighted and it is probably due to the indiscriminate use of carbapenems in this particular hospital or to the lack of a controlled use of carbapenems in intrahospital infections, leading to the emergence of MDR strains. Other studies have shown that *P. aeruginosa* strains isolated from patients subjected to prolonged antimicrobial treatments are more prone to adapt to antimicrobial agents and to become MDR strains; this selection phenomenon is the reason behind the difficulty to control infections caused by MDR strains[@B25]^,^[@B26].

The percentages of MDR and XDR strains in the present study were higher than those reported by Vega and Dowzicky[@B27] who studied antimicrobial susceptibility among gram-positive and gram-negative bacteria from Latin American between 2004 and 2015; a percentage of 26.7% of MDR *P. aeruginosa* was found and the countries presenting the highest percentages of MDR *P. aeruginosa* isolates were Guatemala, Venezuela, Honduras and Brazil (43.8, 32.6, 31.9 and 31.5%, respectively).

Pigment production was the most frequent virulence factor in HUAPA strains throughout the evaluated periods, both in susceptible and LDR strains. Even though pigment production was somewhat higher in MDR and XDR strains, the difference was not statistically significant. The simultaneous production of pigments by *P. aeruginosa* strains from HUAPA was more evident when MDR and XDR strains were subjected to antimicrobial susceptibility tests. The presence of pigments is the distinctive characteristic of the *fluorescens* group of *Pseudomonas* species, and it is also an evidence of the increased virulence of strains found at this hospital. Pigments are necessary for infection to occur in patients. Moreover, pyoverdine and pyomelanin facilitate virulence, biofilm development allowing species to establish chronic infections[@B4]^,^[@B28]. Pigment combinations have been associated with the status or severity of infections caused by *P. aeruginosa*[@B26].

Another important aspect of pyoverdine synthesis in *P. aeruginosa* is its quorum sensor (QS) regulation mechanism, which modulates the existence of other virulence factors such as proteases, exotoxins and biofilm[@B4].

Among the other virulence factors identified in HUAPA strains, such as gelatinases, hemolysins and DNases, only hemolysins were associated with MDR, but production of these factors is variable in *P. aeruginosa* strains. Georgescu *et al*.[@B18] reported that the most frequently expressed soluble virulence factors are beta-hemolysins (83.3%) and gelatinases (66.7%) and less frequently DNases (16.7%), whereas Holban *et al*.[@B29] reported an increase in DNases and a decrease in gelatinases in wound secretion isolates.

In HUAPA strains, beta-hemolysin production plays an important role in spreading the infection and extending wounds, since these enzymes (which form pores on cell membranes) facilitate the invasion of *Pseudomonas* into eukaryotic cells, protecting the bacterium from the host\'s defense mechanisms and the antimicrobial treatment[@B14].

For their part, DNases have important implications for virulence because they degrade extracellular DNA that will be used as a source of nitrogen, carbon and phosphate; they support *P. aeruginosa*\'s biofilm matrix maintenance and their role in cell signaling to induce the expression of genes essential for resistance to antibiotics have been evidenced, leading to evasion of the host immune system[@B30].

Gelatinase production in HUAPA strains was also an important virulence factor, since proteases degrade a variety of proteins, including matrix components of different cells. Galdino *et al*.[@B31], studying clinical strains of *P. aeruginosa* from Brazil, observed that gelatinase and elastase activities and the level of production varied depending on the bacteria\'s site of isolation and antimicrobial susceptibility.

Another virulence factor evaluated in the present study was SST3 (Secretion System Type 3) because of the detection of the *exo*S and *exo*U genes in HUAPA strains. The *exo*U gene was associated with MDR, and its highest frequency was found in wound and bronchial secretions and blood samples from HUAPA patients, which has also been reported by Holban *et al*.[@B32], who detected higher proportions of positive results for *exo*S than for the *exo*U enzyme. These genes are traits of clinical *P. aeruginosa* strains that have *exo*U secretion, higher impact on mortality, persistence of chronic diseases and dissemination of *P. aeruginosa* infections in comparison the *exo*S strain secretors, but it can vary depending on the site and the characteristics of the disease[@B33]^,^[@B34].

According to Feltman *et al*.[@B33], *exo*S and *exo*U distribution is not random and the authors found that most isolates carrying *exo*S sequences lack *exo*U, and vice versa, which was confirmed by the results of 115 *P. aeruginosa* clinical and environmental isolates among which 82 contained *exo*S and 31 contained *exo*U, and only one isolate contained both genes.

Production of biofilms by *P. aeruginosa* has been associated with an increase on antimicrobial resistance[@B35]^,^[@B36], by means of resistance genes accumulation and also to the fact that biofilms matrix penetration is difficult for antimicrobial agents.

Resistance to antipseudomonal beta-lactam antibiotics is apparently proportional to the increment of infection chronicity, which is in turn associated with biofilm formation and pyoverdine production[@B26]. More studies on antimicrobial resistance and simultaneous production of virulence factors are essential to understand the behavior of pathogenenic bacteria and to develop effective therapeutic strategies[@B6].

Results of the present study showed that susceptible strains with class I integrons began to appear during the 2012 period, possibly acquired by horizontal transference of MDR or XDR *P. aeruginosa* intrahospital strains and increased in number as well as integron acquisition. Integrons have resistance cassettes that may favor the presence of MDR strains, which has been reported in *P. aeruginosa* strains with class I integrons[@B37]^--^[@B40]. Integrons were found to be associated with MDR strains of *Pseudomonas*, however, Fonseca *et al*.[@B23] found no correlations between the presence of class I integron and MDR in clinical *P. aeruginosa* strains. Other studies have shown that *P. aeruginosa* isolates from patients with a history of long antimicrobial treatment developed MDR/XDR; long hospital stay and readmission to the Intensive Care Unit were associated with MDR in patients with bacteremia caused by this species[@B41]^,^[@B42].

Results of the present study demonstrated that HUAPA strains increased their MDR throughout the different sampling periods; these strains were also characterized by the presence of different virulence factors (pigments, biofilms, among others) favoring infections by *P. aeruginosa*. However, only hemolysins, *exo*U genes and class I integrons were associated with MDR/XDR.

The present study demonstrated that *P. aeruginosa* employs various mechanisms to maintain infection in patients admitted to the studied hospital; in addition to risk factors identified by the study (attending the Intensive Care Unit, previous antimicrobial treatment, long hospital stay), these conditions predispose patients to *P. aeruginosa* MDR strains infections, which require infection-specific therapeutic, isolation and control measures to decrease both, the infection rate and the dissemination of bacterial resistance mechanisms in hospitals.
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